AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison of Laryngeal Mask Airway Versus Endotracheal Intubation in Pediatric Laparoscopic Inguinal Hernia Repair

RecruitingNAAges 1 Year - 10 YearsAllSaglik Bilimleri Universitesi Gazi Yasargil Train…
💬

In plain words

What the trial is, and whether it could suit you

Inguinal hernia is one of the most common conditions requiring surgical intervention in childhood, with a reported lifetime prevalence of 1-4%. With the increasing use of minimally invasive techniques such as PIRS (Percutaneous Internal Ring Suturing) among laparoscopic surgical procedures, perioperative anesthesia and airway management have become a critical area of clinical decision-making. The traditional approach in pediatric laparoscopic surgery is endotracheal intubation (ETT). Although ETT provides reliable airway control, it carries certain disadvantages. In contrast, the laryngeal mask airway (LMA) is less invasive and is associated with faster recovery. Systematic reviews and meta-analyses conducted in recent years have shown that the LMA may be safe for ventilation in pediatric laparoscopy, reduces peak airway pressure, and shortens recovery time. No well-designed, multicenter

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * being between 1 and 10 years of age, * having a planned laparoscopic inguinal hernia repair, * being classified as ASA I-II, * having given informed consent from the parent. Exclusion Criteria: * Obesity (body weight \>95th percentile), * symptomatic gastroesophageal reflux, * high risk of aspiration, * upper airway anomalies, * history of difficult intubation, * acute respiratory tract infection, * emergency surgical indication, * need for conversion from laparoscopy to open surgery, * presence of additional systemic risks such as immunodeficiency/malignancy.
💊

What it tests

  • General Aneasthesia
📍

Where

1 site
Dicle University
Diyarbakır, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy